Investigating the relationship between IC genes and other biomarkers of immunotherapy responsiveness, they also found a significant association between the expression of a series of IC genes and CRC prognosis, as well as between biomarkers of responsiveness, neoantigens, and MMR status. This evidence concerns the gene MRC1 and colorectal carcinoma.